Researchers at the University of Geneva (UNIGE) have made significant strides in understanding why some tumors spread while others remain localized. Their study, published in Cell Reports, focuses on colon cancer cells and reveals key factors influencing tumor metastasis. By analyzing gene expression patterns, the team identified specific markers that can predict the likelihood of cancer spreading. They developed an innovative AI tool, MangroveGS, which utilizes these genetic signals to forecast metastasis risk across various cancers, including breast and lung cancers. This tool boasts nearly 80% accuracy, surpassing existing prediction methods. The research highlights cancer as a complex, structured biological process rather than random cell behavior. By integrating MangroveGS into clinical practice, healthcare providers can personalize treatment plans, preventing overtreatment in low-risk patients while intensifying care for high-risk individuals. This advancement promises to optimize clinical trials and improve therapeutic outcomes, ultimately enhancing patient care in oncology.
Share
Read more